These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 3907754)

  • 1. Developing rat brain binds monoiodinated insulin isomers similarly to other extrahepatic target tissues.
    Kappy MS; Clarke DW; Raizada MK; Boyd FT; Frank BH
    Brain Res; 1985 Dec; 360(1-2):195-202. PubMed ID: 3907754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor binding and biological activity of specifically labeled [125I]- and [127I]monoiodoinsulin isomers in isolated rat adipocytes.
    Peavy DE; Abram JD; Frank BH; Duckworth WC
    Endocrinology; 1984 May; 114(5):1818-24. PubMed ID: 6370667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential binding of monoiodinated insulins to muscle and liver derived receptors and activation of the receptor kinase.
    Burant CF; Treutelaar MK; Peavy DE; Frank BH; Buse MG
    Biochem Biophys Res Commun; 1988 May; 152(3):1353-60. PubMed ID: 2837184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoiodoinsulin labelled in tyrosine residue 16 or 26 of the insulin B-chain. Preparation and characterization of some binding properties.
    Linde S; Sonne O; Hansen B; Gliemann J
    Hoppe Seylers Z Physiol Chem; 1981 Jun; 362(6):573-9. PubMed ID: 7024083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The degradation of monoiodotyrosyl insulin isomers by insulin protease.
    Ryan MP; Peavy DE; Frank BH; Duckworth WC
    Endocrinology; 1984 Aug; 115(2):591-9. PubMed ID: 6378594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoiodoinsulin labelled in tyrosine residue 16 or 26 of the B-chain or 19 of the A-chain. II. Characterization of the kinetic binding constants and determination of the biological potency.
    Sonne O; Linde S; Larsen TR; Gliemann J
    Hoppe Seylers Z Physiol Chem; 1983 Feb; 364(2):101-10. PubMed ID: 6341199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the receptor binding properties of monoiodoinsulin isomers and the identification of different insulin receptor specificities in hepatic and extrahepatic tissues.
    Podlecki DA; Frank BH; Kao M; Horikoshi H; Freidenberg G; Marshall S; Ciaraldi T; Olefsky JM
    Diabetes; 1983 Aug; 32(8):697-704. PubMed ID: 6347766
    [No Abstract]   [Full Text] [Related]  

  • 8. Tyrosine A14[125I]monoiodoinsulin: Preparation, Biologic Properties, and long-term stability.
    Linde S; Hansen B; Sonne O; Holst JJ; Gliemann J
    Diabetes; 1981 Jan; 30(1):1-8. PubMed ID: 7014299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Heterogeneity of the immunoreactivity of A14, A19, B16 and B26- (125I) monoiodoinsulin to different species of anti-insulin immuno sera].
    Zhou W; Li S; Deng S
    Hua Xi Yi Ke Da Xue Xue Bao; 1993 Dec; 24(4):369-72. PubMed ID: 8150434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of iodination site on binding of radiolabeled ligand by insulin antibodies and insulin autoantibodies.
    Diaz JL; Wilkin TJ
    Clin Chem; 1988 Feb; 34(2):356-9. PubMed ID: 2449302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of insulin degradation products generated in liver endosomes: in vivo and in vitro studies.
    Clot JP; Janicot M; Fouque F; Desbuquois B; Haumont PY; Lederer F
    Mol Cell Endocrinol; 1990 Sep; 72(3):175-85. PubMed ID: 2289630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [125I]diiodoinsulins. Binding affinities, biologic potencies, and properties of their decay products.
    Pérez Maceda B; Linde S; Sonne O; Gliemann J
    Diabetes; 1982 Jul; 31(7):634-40. PubMed ID: 7160541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The preparation and characterization of mono-iodinated photoreactive analogs of insulin.
    Heidenreich KA; Yip CC; Frank BH; Olefsky JM
    Biochem Biophys Res Commun; 1985 Feb; 126(3):1138-45. PubMed ID: 3884003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Degradation of the four monoiodoinsulin isomers by the insulin protease of rat liver.
    Brush JS; Sonne O; Gliemann J
    Biochim Biophys Acta; 1983 Jun; 757(3):269-73. PubMed ID: 6342683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for separate handling in vivo of different regions of the insulin molecule using A14- and B1-labeled insulin tracers.
    Cockram CS; Jones RH; Boroujerdi MA; Sönksen PH
    Diabetes; 1984 Aug; 33(8):721-7. PubMed ID: 6378697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 125I-insulin metabolism by rat liver cells: preferential binding and degradation of insulin labeled at TyrA14.
    Misbin RI; Buynitzky SJ; Almira EC
    Drug Metab Dispos; 1982; 10(2):153-5. PubMed ID: 6124401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A14-[125I]monoiodoinsulin purified by different high-performance liquid chromatographic procedures and by polyacrylamide gel electrophoresis: preparation, immunochemical properties and receptor binding affinity.
    Benzi L; Pezzino V; Marchetti P; Gullo D; Cecchetti P; Masoni A; Vigneri R; Navalesi R
    J Chromatogr; 1986 Jun; 378(2):337-47. PubMed ID: 3525587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of radiochemical purity and tissue binding of labelled insulin prepared by lactoperoxidase and chloramine T iodination.
    Zórad S; Svábová E; Klimes I; Macho L
    Endocrinol Exp; 1985 Dec; 19(4):267-75. PubMed ID: 3910407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Processing and presentation of insulin. II. Evidence for intracellular, plasma membrane-associated and extracellular degradation of human insulin by antigen-presenting B cells.
    Semple JW; Ellis J; Delovitch TL
    J Immunol; 1989 Jun; 142(12):4184-93. PubMed ID: 2656861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High performance liquid chromatographic analysis of insulin degradation products from a cultured kidney cell line.
    Duckworth WC; Hamel FG; Liepnieks J; Frank BH; Yagil C; Rabkin R
    Endocrinology; 1988 Dec; 123(6):2701-8. PubMed ID: 3058457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.